A Randomized Controlled Clinical Trial Comparing the Efficacy of Dead Sea Mineral-Enriched Body Lotion versus Two Types of Placebo in the Treatment of Cutaneous Dryness, Itching, Peeling and Tightness in Hemodialysis Patients (EDIT)

2009 ◽  
Vol 113 (3) ◽  
pp. c169-c176 ◽  
Author(s):  
Mona Boaz ◽  
Larisa Shtendik ◽  
Miriam Oron ◽  
Meital Portugal-Cohen ◽  
Ron Kohen ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Dead Sea ◽  
Hemodialysis Patients ◽  
Controlled Clinical Trial ◽  
Randomized Controlled Clinical Trial ◽  
Randomized Controlled

scholarly journals The effect of the omega-3 supplement on uremic pruritus in hemodialysis patients; a double-blind randomized controlled clinical trial

2017 ◽  
Vol 8 (2) ◽  
pp. 13-13
Author(s):  
Shokouh Shayanpour ◽  
Seyed Seyfollah Beladi Mousavi ◽  
Parastoo Lakhaye Rizi ◽  
Bahman Cheraghian
Keyword(s):  
Clinical Trial ◽  
Hemodialysis Patients ◽  
Chronic Hemodialysis ◽  
Controlled Clinical Trial ◽  
Omega 3 ◽  
Randomized Controlled Clinical Trial ◽  
Double Blind ◽  
Uremic Pruritus ◽  
Randomized Controlled ◽  
Uremic Syndrome

Background: Chronic kidney disease (CKD) and uremic syndrome cause malfunction in most of organs including skin. Objectives: This study was designed to investigate the effects of omega-3 supplement on uremic pruritus in chronic hemodialysis patients. Patients and Methods: In this double-blind randomized controlled clinical trial study (#IRCT cod; 29363; http://irct.ir/trial/29363), the effect of the omega-3 supplement on uremic pruritus was assessed in 64 chronic hemodialysis patients (using standard 5-D itch scale questionnaire). Patients were surveyed at the hemodialysis department of Imam Khomeini and Razi hospitals in Ahvaz city, Iran. Results: We found that the mean score of itching degree in the intervention and the placebo groups decreased from 3.56 to 1.72 (P<0.001) and 3.63 to 3.09 (P<0.05) respectively. Conclusions: In our study, the omega-3 supplement could reduce uremic pruritus in chronic hemodialysis patients.

A randomized controlled clinical trial of 4% sodium citrate versus heparin as locking solution for temporary dialysis catheters among hemodialysis patients

2018 ◽  
Vol 90 (5) ◽  
pp. 341-349 ◽  
Author(s):  
Abdel Basset E. Abdel Azim ◽  
Tamer W. ElSaid ◽  
Heba W. El Said ◽  
Walid Hemida ◽  
Salwa Zaghlool ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Sodium Citrate ◽  
Hemodialysis Patients ◽  
Controlled Clinical Trial ◽  
Randomized Controlled Clinical Trial ◽  
Randomized Controlled

scholarly journals The effect of a care plan based on the Roy adaptation model on general health in hemodialysis patients; a randomized controlled clinical trial

2020 ◽  
Vol 9 (2) ◽  
pp. e11-e11
Author(s):  
Monir Nobahar ◽  
Mohadese Saffari ◽  
Hassan Babamohamadi ◽  
Nemat Sotodehasl ◽  
Majid Mirmohammadkhani
Keyword(s):  
Clinical Trial ◽  
General Health ◽  
Intervention Group ◽  
Hemodialysis Patients ◽  
Care Plan ◽  
Controlled Clinical Trial ◽  
Roy Adaptation Model ◽  
Randomized Controlled Clinical Trial ◽  
Randomized Controlled ◽  
Adaptation Model

Introduction: Evidence suggests that end-stage renal disease (ESRD) significantly affects general health in the patients, causing their general health to be poorer compared to the general population. The Roy adaptation model (RAM) is the best one for ESRD patients. Objectives: The present study aimed to determine the effect of a RAM-based care plan on general health in hemodialysis patients. Patients and Methods: This randomized controlled clinical trial conducted on 60 hemodialysis patients in Iran. The data collected using a demographic questionnaire and the general health questionnaire-28 (GHQ-28). In the intervention group, the Roy assessment form was completed and the RAM-based care plan was then trained in four group sessions over 4 weeks. Individual sessions were also held if required and patients followed-up for 2 weeks. The control group received only routine care. At the end of the follow-up, general health was re-assessed in the patients. The findings were analysed using t test, the chi-square test and the McNemar test. Results: Despite observing no significant differences between the two groups in terms of general health levels before the intervention (P=0.530), the difference was significant after the intervention (P=0.028), since the mean score of general health decreased by 4.07 in the intervention group compared to before the intervention (P=0.003). The intervention significantly affected the subscales of somatic symptoms (P=0.013), anxiety and insomnia (P=0.006), social dysfunction (P=0.016) and depression (P=0.031). Conclusion: The findings suggested the positive effects of using the RAM on general health in hemodialysis patients. The RAM is therefore recommended that be used as a holistic care approach to improving general health in these patients

Effects of pomegranate peel extract and vitamin E on the inflammatory status and endothelial function in hemodialysis patients: a randomized controlled clinical trial

2020 ◽  
Vol 11 (9) ◽  
pp. 7987-7993
Author(s):  
Tina Jafari ◽  
Aziz A. Fallah ◽  
Ali Reyhanian ◽  
Elham Sarmast
Keyword(s):  
Clinical Trial ◽  
Vascular Function ◽  
Hemodialysis Patients ◽  
Controlled Clinical Trial ◽  
Randomized Controlled Clinical Trial ◽  
Pomegranate Peel ◽  
Randomized Controlled ◽  
Inflammatory Status ◽  
Pomegranate Peel Extract ◽  
Peel Extract

This study showed that combination therapy with PPE and Vit E is more effective than single therapy to ameliorate inflammation and vascular function in hemodialysis patients.

Sign in / Sign up

Export Citation Format

Share Document